DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
1-Year Est. Return 0.48%
This Quarter Est. Return
1 Year Est. Return
-0.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$99.1M
AUM Growth
-$6.37M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
65
New
Increased
Reduced
Closed

Top Buys

1
+$3.9M
2
+$3.01M
3
+$2.52M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$1.67M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$1.04M

Top Sells

1
+$4.42M
2
+$2.08M
3
+$1.47M
4
KERX
Keryx Biopharmaceuticals Inc
KERX
+$1.42M
5
GLMD icon
Galmed Pharmaceuticals
GLMD
+$766K

Sector Composition

1 Healthcare 55.18%
2 Financials 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$13M 13.14%
110,928
-4,700
2
$10.5M 10.58%
407,053
3
$8.82M 8.89%
598,883
+27,896
4
$5.04M 5.09%
384,154
5
$4.03M 4.07%
109,418
6
$3.9M 3.94%
+152,002
7
$3.34M 3.37%
263,541
8
$3.31M 3.34%
675,650
+515,028
9
$3.21M 3.23%
384,794
10
$3.19M 3.22%
1,718,719
-8,106
11
$3.12M 3.14%
128,844
+11,000
12
$3.01M 3.03%
+145,342
13
$2.12M 2.14%
60,054
-10,034
14
$2.01M 2.02%
3,369
+987
15
$1.67M 1.69%
+36,900
16
$1.59M 1.6%
148,600
17
$1.58M 1.59%
235,645
18
$1.29M 1.3%
240,190
19
$1.22M 1.23%
486,062
+44,203
20
$1.12M 1.13%
42,162
21
$1.09M 1.1%
82,250
22
$1.04M 1.04%
+66,141
23
$1.01M 1.01%
650
-495
24
$1M 1.01%
9,400
25
$983K 0.99%
1,062,500
1
2 3